Clinical Trials: Antineoplastic Agents
- Alanosine 2 studies
- Albendazole 43 studies
- Aldesleukin 302 studies
- Alemtuzumab 257 studies
- Alitretinoin 13 studies
- Allyl sulfide 3 studies
- Altretamine 21 studies
- Aminoglutethimide 2 studies
- Ammonium trichloro(dioxoethylene-O,O'-)tellurate 9 studies
- Amonafide 5 studies
- Amrubicin 17 studies
- Anastrozole 187 studies
- Angiogenesis Inhibitors 2858 studies
- Angiopeptin 48 studies
- Angiostatins 3 studies
- Annamycin 3 studies
- Antibiotics, Antineoplastic 3280 studies
- Anticarcinogenic Agents 353 studies
- Antimetabolites, Antineoplastic 5099 studies
- Antimitotic Agents 2532 studies
- Antineoplastic Agents, Alkylating 3146 studies
- Antineoplastic Agents, Hormonal 3104 studies
- Antineoplastic Agents, Phytogenic 3643 studies
- Apaziquone 7 studies
- Arginine butyrate 5 studies
- Arsenic trioxide 96 studies
- Ascorbate-2-phosphate 1 study
- Azacitidine 190 studies
- Azathioprine 93 studies
- Azelaic acid 22 studies
- BBR 3464 2 studies
- Belotecan 6 studies
- Bendamustine 135 studies
- Betulinic acid 1 study
- Bevacizumab 1364 studies
- Bexarotene 39 studies
- Bicalutamide 126 studies
- Bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II) 1 study
- Bizelesin 1 study
- Bleomycin 118 studies
- Bortezomib 594 studies
- Bromodeoxyuridine 4 studies
- Bryostatin 1 38 studies
- Busulfan 366 studies
- Buthionine Sulfoximine 3 studies
- Cabergoline 29 studies
- Camptothecin 368 studies
- Capecitabine 851 studies
- Carboxyamido-triazole 8 studies
- Carmustine 177 studies
- Cetuximab 533 studies
- Chlorambucil 32 studies
- Cidofovir 24 studies
- Clofarabine 118 studies
- Colchicine 63 studies
- Combretastatin 15 studies
- Combretastatin A-4 12 studies
- Cordycepin 2 studies
- Cryptoxanthin 2 studies
- Cyclophosphamide 1936 studies
- Cytarabine 731 studies
- Dacarbazine 437 studies
- Dactinomycin 41 studies
- Daunorubicin 184 studies
- Decitabine 108 studies
- Denileukin diftitox 46 studies
- Dexamethasone 1038 studies
- Dienogest 19 studies
- Docetaxel 1350 studies
- Dofequidar 1 study
- Dolastatin 10 7 studies
- Doxifluridine 5 studies
- Doxorubicin 1261 studies
- Ecabet 5 studies
- Elsamicin A 2 studies
- Endostatins 35 studies
- Epigallocatechin gallate 37 studies
- Epirubicin 239 studies
- Epothilone B 54 studies
- Epothilones 119 studies
- Estramustine 50 studies
- Etoposide 913 studies
- Etoposide phosphate 913 studies
- Exatecan 16 studies
- Exemestane 116 studies
- Farnesylthiosalicylic acid 2 studies
- Fenretinide 38 studies
- Fiacitabine 1 study
- Flavopiridol 59 studies
- Floxuridine 41 studies
- Fludarabine 770 studies
- Fludarabine monophosphate 770 studies
- Fluorouracil 1637 studies
- Flutamide 51 studies
- Fosfestrol 2 studies
- Fotemustine 5 studies
- Fucoidan 2 studies
- Fulvestrant 91 studies
- Gallium nitrate 5 studies
- Gefitinib 254 studies
- GEL protein, Gelonium multiflorum 1 study
- Geldanamycin 10 studies
- Gemcitabine 1278 studies
- Gemtuzumab 61 studies
- Genistein 38 studies
- Goserelin 144 studies
- Gossypol acetic acid 20 studies
- Grape Seed Extract 14 studies
- Gusperimus 6 studies
- Halofuginone 2 studies
- Harringtonines 10 studies
- Homoharringtonine 11 studies
- Honokiol 1 study
- Hypericin 2 studies
- Idarubicin 137 studies
- Ifosfamide 295 studies
- Imatinib 473 studies
- Imiquimod 86 studies
- Indole-3-carbinol 6 studies
- Interferon Alfa-2a 825 studies
- Interferon Alfa-2b 268 studies
- Interferon beta 1a 139 studies
- Interferon omega 1 1 study
- Interferon Type I, Recombinant 1 study
- Interleukin-12 95 studies
- Iodine-131 anti-B1 antibody 49 studies
- Irinotecan 747 studies
- Irofulven 19 studies
- ISIS 5132 2 studies
- Isophosphamide mustard 295 studies
- Krestin 99 studies
- KRN 7000 5 studies
- Lanreotide 48 studies
- Lapatinib 237 studies
- Lenalidomide 420 studies
- Letrozole 209 studies
- Leuprolide 178 studies
- Levan 5 studies
- Liarozole 1 study
- Lometrexol 2 studies
- Lomustine 50 studies
- Lonidamine 2 studies
- Lurtotecan 6 studies
- Lycopene 34 studies
- Mafosfamide 5 studies
- Maxacalcitol 4 studies
- Mebendazole 10 studies
- Mechlorethamine 393 studies
- Medroxyprogesterone Acetate 83 studies
- Megestrol 50 studies
- Megestrol Acetate 50 studies
- Melphalan 511 studies
- Methotrexate 1007 studies
- Methylprednisolone Hemisuccinate 656 studies
- Methyltestosterone 320 studies
- Miltefosine 21 studies
- Mitolactol 1 study
- Mitomycins 138 studies
- Mitotane 9 studies
- Molgramostim 7 studies
- Monoclonal antibody 17-1A 3 studies
- Motexafin gadolinium 36 studies
- Mycophenolic Acid 520 studies
- N(1),N(11)-diethylnorspermine 2 studies
- N(1),N(14)-bis(ethyl)homospermine 1 study
- Nedaplatin 7 studies
- Nilutamide 9 studies
- Nitrogen Mustard Compounds 109 studies
- Nolatrexed 1 study
- NSC 366140 8 studies
- O(6)-benzylguanine 32 studies
- O-(chloroacetylcarbamoyl)fumagillol 2 studies
- Octreotide 133 studies
- Oltipraz 3 studies
- ONYX015 1 study
- Oprelvekin 11 studies
- Oxaliplatin 866 studies
- Paclitaxel 1659 studies
- Pegaspargase 79 studies
- Pemetrexed 406 studies
- Penclomedine 2 studies
- Perilla alcohol 7 studies
- Phenethyl isothiocyanate 3 studies
- Phenylacetic acid 8 studies
- Phosphoramide Mustards 1 study
- Pirarubicin 3 studies
- Pirfenidone 17 studies
- Piritrexim 1 study
- Pixantrone 12 studies
- PK 11195 3 studies
- Podophyllotoxin 7 studies
- Poly(maleic acid-styrene)neocarzinostatin 1 study
- Porfiromycin 2 studies
- Prednimustine 1 study
- Prednisolone 656 studies
- Prednisone 808 studies
- Raltitrexed 14 studies
- Ranpirnase 4 studies
- Resveratrol 43 studies
- Retinamide 7 studies
- Retinol acetate 51 studies
- Retinol palmitate 166 studies
- Rituximab 1108 studies
- Romidepsin 46 studies
- Roscovitine 3 studies
- S 1 (combination) 164 studies
- Satraplatin 16 studies
- Selenomethylselenocysteine 3 studies
- Semustine 2 studies
- Seocalcitol 2 studies
- Sirolimus 1213 studies
- Soblidotin 3 studies
- Sorafenib 493 studies
- Specific substance maruyama 2 studies
- Squalamine 6 studies
- Streptozocin 8 studies
- SU 5416 31 studies
- Sulforafan 15 studies
- Sulindac sulfone 12 studies
- Sunitinib 389 studies
- Talaporfin 11 studies
- Tamoxifen 265 studies
- Tanshinone 1 study
- Taurolidine 7 studies
- Taxane 208 studies
- Tegafur 54 studies
- Temoporfin 4 studies
- Temozolomide 461 studies
- Testolactone 4 studies
- Tetrathiomolybdate 10 studies
- Thalidomide 616 studies
- Thioguanine 65 studies
- Thiotepa 159 studies
- Thymalfasin 12 studies
- Thymogen 3 studies
- Tibolone 19 studies
- Tipifarnib 78 studies
- Tirapazamine 16 studies
- Topoisomerase I Inhibitors 969 studies
- Topoisomerase Inhibitors 984 studies
- Topotecan 277 studies
- Toremifene 17 studies
- Trabectedin 37 studies
- Trabedersen 3 studies
- Trastuzumab 471 studies
- Treosulfan 21 studies
- Trichosanthin 1 study
- Tricyclodecane-9-yl-xanthogenate 1 study
- Trilostane 1 study
- Trimetrexate 17 studies
- Triptolide 1 study
- Triptorelin 60 studies
- Trofosfamide 3 studies
- Troxacitabine 4 studies
- Tumor Necrosis Factor Ligand Superfamily Member 15 1 study
- Valrubicin 8 studies
- Vapreotide 2 studies
- Vesnarinone 4 studies
- Vinblastine 270 studies
- Vinca Alkaloids 7 studies
- Vincristine 683 studies
- Vindesine 35 studies
- Vinorelbine 270 studies
- Viscum album peptide 3 studies
- Vorinostat 196 studies
- ZD 9331 1 study
- Zinostatin 1 study
- 10-deazaaminopterin 12 studies
- 10-hydroxycamptothecin 6 studies
- 2'-deoxy-2'-(fluoromethylene)cytidine 3 studies
- 2,3-dihydro-1H-imidazo(1,2-b)pyrazole 2 studies
- 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide 4 studies
- 2-chloro-3'-deoxyadenosine 15 studies
- 2-methoxyestradiol 9 studies
- 3,3'-diindolylmethane 1 study
- 4'-deoxydoxorubicin 4 studies
- 4'-N-benzoylstaurosporine 17 studies
- 4-phenylbutyric acid 36 studies
- 5,6-dimethylxanthenoneacetic acid 18 studies
- 5-(1-aziridinyl)-2,4-dinitrobenzamide 1 study
- 6-Mercaptopurine 128 studies
- 6-O-palmitoylascorbic acid 2 studies
- 7-hydroxystaurosporine 22 studies
- 8-chloro-cyclic adenosine monophosphate 2 studies
- 9-amino-20-camptothecin 10 studies
- 9-nitrocamptothecin 24 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://www.clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_ANeo
